SPONSOR
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Advanced ALK/ROS1-positive NSCLCCarcinoma, Non-Small-Cell Lung (NSCLC)Lung AdenocarcinomaALK-positive Non-small Cell Lung Cancer (NSCLC)Cognitive DysfunctionDepression
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Advanced ALK/ROS1-positive NSCLC, Carcinoma, Non-Small-Cell Lung (NSCLC), Lung Adenocarcinoma, ALK-positive Non-small Cell Lung Cancer (NSCLC).
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
How many clinical trials has Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo, of which 1 are actively recruiting participants. These trials cover conditions including Advanced ALK/ROS1-positive NSCLC, Carcinoma, Non-Small-Cell Lung (NSCLC), Lung Adenocarcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo research focus on?
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo clinical trials span Advanced ALK/ROS1-positive NSCLC, Carcinoma, Non-Small-Cell Lung (NSCLC), Lung Adenocarcinoma, ALK-positive Non-small Cell Lung Cancer (NSCLC), Cognitive Dysfunction, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo clinical trial?
To participate in a Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo trials with current recruitment status updated daily.
Clinical Trials by Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology